Cullinan Therapeutics Stock (NASDAQ:CGEM), Quotes and News Summary

Q: What sector and industry does Cullinan Therapeutics (CGEM) operate in?

Cullinan Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Cullinan Therapeutics Stock (NASDAQ: CGEM) stock price, news, charts, stock research, profile.

Open	$18.500
Close	-
Volume / Avg.	919.470K / 541.410K
Day Range	18.230 - 19.430
52 Wk Range	7.640 - 20.620
Market Cap	$827.291M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	63
Short Interest	4.1%
Days to Cover	4.15

Recent News

Why Is Cullinan Therapeutics Stock Trading Higher On Wednesday?

Explore the use of Amgen's Blincyto in treating severe systemic sclerosis, shedding light on Cullinan Therapeutics' CLN-978 potential for autoimmune diseases, particularly systemic lupus erythematosus.

Vandana Singh

Hilton Worldwide Reports Upbeat Results, Joins Hasbro, Vertiv Holdings And Other Big Stocks Moving Higher On Wednesday

Avi Kapoor

Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Shares of The Travelers Companies, Inc. (NYSE: TRV) fell sharply during Wednesday’s session following first-quarter earnings.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Feb

Mar

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating

4.4

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Cullinan Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Cullinan Therapeutics Inc is a biopharmaceutical company. It has diversified portfolio of clinical-s...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Cullinan Therapeutics (CGEM) stock?

You can purchase shares of Cullinan Therapeutics (NASDAQ: CGEM) through any online brokerage.

View our list of the best stock brokerages.

Who are Cullinan Therapeutics's (CGEM) competitors?

Other companies in Cullinan Therapeutics’s space includes: Immunome (NASDAQ:IMNM), ARS Pharmaceuticals (NASDAQ:SPRY), Cabaletta Bio (NASDAQ:CABA), 89bio (NASDAQ:ETNB) and Cogent Biosciences (NASDAQ:COGT).

What is the target price for Cullinan Therapeutics (CGEM) stock?

The latest price target for Cullinan Therapeutics (NASDAQ: CGEM) was reported by JonesTrading on Wednesday, April 17, 2024. The analyst firm set a price target for 26.00 expecting CGEM to rise to within 12 months (a possible 35.35% upside). 14 analyst firms have reported ratings in the last year.

Current Stock Price for Cullinan Therapeutics (CGEM)?

The stock price for Cullinan Therapeutics (NASDAQ: CGEM) is $19.21 last updated Today at April 25, 2024 at 2:40 PM EDT.

Does Cullinan Therapeutics (CGEM) pay a dividend?

There are no upcoming dividends for Cullinan Therapeutics.

When is Cullinan Therapeutics (NASDAQ:CGEM) reporting earnings?

Cullinan Therapeutics’s Q1 earnings are confirmed for Thursday, May 9, 2024.

Is Cullinan Therapeutics (CGEM) going to split?

There is no upcoming split for Cullinan Therapeutics.

What sector and industry does Cullinan Therapeutics (CGEM) operate in?

Cullinan Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-